Creasallis Limited
Creasallis is the creative antibody solutions company looking to alleviate bottlenecks in antibody therapies. The debut technology, CreaTap is a technology to improve the penetration of cancer based antibody drugs into the tumour. Creasallis is a start up from the Accelerate@ Babraham 2021 cohort and was founded by the CEO Zahra Jawad.